Fennec Pharmaceuticals Inc. Common Stock (FENC) is a publicly traded Healthcare sector company. As of August 4, 2026, FENC trades at $10.11 with a market cap of $333.13M and a P/E ratio of -29.63. FENC moved +5.74% today. Year to date, FENC is +31.30%; over the trailing twelve months it is +21.51%. Its 52-week range spans $4.68 to $11.31. Analyst consensus is strong buy with an average price target of $15.50. Rallies surfaces FENC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest FENC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $10.11 |
| Market Cap | $333.13M |
| P/E Ratio | -29.63 |
| EPS | $-0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.31 |
| 52-Week Low | $4.68 |
| Volume | 138.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $44.64M |
| Net Income | $-9.74M |
| Gross Margin | 0.00% |
4 analysts cover FENC: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.50.